Optimi Health Accelerates Psilocybin Clinical Trial Program with IMPACT
09 mars 2021 09h00 HE
|
Optimi Health Corp.
VANCOUVER, British Columbia, March 09, 2021 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (“Optimi” or the “Company”), developers of a vertically integrated functional mushroom brand focused...